Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2
Background The dedifferentiated variant of chondrosarcoma is highly aggressive and carries an especially grim prognosis. While chemotherapeutics has failed to benefit patients with dedifferentiated chondrosarcoma significantly, preclinical chemosensitivity studies have been limited by a scarcity of...
Enregistré dans:
Auteurs principaux: | Xiaoyang Li, Dylan C. Dean, Al Ferreira, Scott D. Nelson, Francis J. Hornicek, Shengji Yu, Zhenfeng Duan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
SAGE Publishing
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4bc285e7b973464fabe3bc6c3e5e7cc4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma
par: Pei Liu, et autres
Publié: (2017) -
Establishment and Characterization of NCC-DDLPS4-C1: A Novel Patient-Derived Cell Line of Dedifferentiated Liposarcoma
par: Ryuto Tsuchiya, et autres
Publié: (2021) -
T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
par: Pichaya Thanindratarn, et autres
Publié: (2021) -
Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression
par: Rémy Nicolle, et autres
Publié: (2019) -
Dedifferentiation and proliferation of mammalian cardiomyocytes.
par: Yiqiang Zhang, et autres
Publié: (2010)